Skip to main content
Top
Published in: Drugs & Aging 2/2005

01-02-2005 | Therapy In Practice

Faecal Incontinence in the Elderly

Epidemiology and Management

Author: Professor Arnold Wald

Published in: Drugs & Aging | Issue 2/2005

Login to get access

Abstract

Faecal incontinence occurs in up to 10% of community dwelling persons ≥65 years of age and approximately 50% of nursing home residents. It is a vastly under-reported problem that has a devastating effect on those who experience it as well as their spouses and caregivers.
There are three broad categories of faecal incontinence among the elderly: (i) overflow incontinence; (ii) reservoir incontinence; and (iii) rectosphincteric incontinence. The first two can be diagnosed based upon the patient’s history and physical examination and the response to dietary and pharmacological interventions. The third is assessed by careful physical examination supplemented by diagnostic tests directed towards evaluation of anorectal continence mechanisms. The most important of these is anorectal manometry, which can be supplemented by studies of structure (anal ultrasonography or pelvic floor magnetic resonance imaging) and neuromuscular function (electromyogram). A variety of therapeutic interventions are employed in patients with rectosphincteric incontinence; these include dietary, behavioural, pharmacological and surgical modalities chosen on the basis of the results of diagnostic testing. For isolated internal anal sphincter weakness, a cotton barrier in the anal canal is often effective. Acute sphincter injury is best treated with sphincteroplasty but, otherwise, surgical procedures are of uncertain benefit. Peripheral neurogenic incontinence may be treated with antidiarrhoeal agents, biofeedback techniques and dietary manipulations. Sacral spinal nerve stimulation is a promising new technique for selected patients with neurogenic faecal incontinence and is currently undergoing testing in the US and Europe. Significant improvement in quality of life can be achieved in most elderly persons with faecal incontinence.
Footnotes
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literature
1.
go back to reference Whitehead WE, Wald A, Norton NJ. Treatment options for fecal incontinence. Dis Colon Rectum 2001; 44: 131–42PubMedCrossRef Whitehead WE, Wald A, Norton NJ. Treatment options for fecal incontinence. Dis Colon Rectum 2001; 44: 131–42PubMedCrossRef
2.
go back to reference Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 1996; 91: 33–6PubMed Johanson JF, Lafferty J. Epidemiology of fecal incontinence: the silent affliction. Am J Gastroenterol 1996; 91: 33–6PubMed
4.
go back to reference Chassagne P, Landrin I, Neveu C, et al. Fecal incontinence in the institutionalized elderly: incidence, risk factors and progrnosis. Am J Med 1999; 106: 185–90PubMedCrossRef Chassagne P, Landrin I, Neveu C, et al. Fecal incontinence in the institutionalized elderly: incidence, risk factors and progrnosis. Am J Med 1999; 106: 185–90PubMedCrossRef
5.
go back to reference Harari D, Coshall C, Rudd A, et al. New onset incontinence after stroke: prevalence, natural history, risk factors and impact. Stroke 2003; 34: 144–50PubMedCrossRef Harari D, Coshall C, Rudd A, et al. New onset incontinence after stroke: prevalence, natural history, risk factors and impact. Stroke 2003; 34: 144–50PubMedCrossRef
6.
go back to reference Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum 1998; 41: 1226–9PubMedCrossRef Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin nursing homes: prevalence and associations. Dis Colon Rectum 1998; 41: 1226–9PubMedCrossRef
7.
8.
go back to reference Chiang L, Ouslander J, Schnelle JF, et al. Dually incontinence nursing home residents: clinical characteristics and treatment differences. J Am Geriatr Soc 2000; 48: 673–6PubMed Chiang L, Ouslander J, Schnelle JF, et al. Dually incontinence nursing home residents: clinical characteristics and treatment differences. J Am Geriatr Soc 2000; 48: 673–6PubMed
9.
go back to reference Tariq SH, Morley JE, Prather CM. Fecal incontinence in the elderly patient. Am J Med 2003; 115: 217–27PubMedCrossRef Tariq SH, Morley JE, Prather CM. Fecal incontinence in the elderly patient. Am J Med 2003; 115: 217–27PubMedCrossRef
11.
go back to reference Palmer KR, Corbett CL, Holdsworth CD. Double-blind crossover study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79(6): 1272–5PubMed Palmer KR, Corbett CL, Holdsworth CD. Double-blind crossover study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology 1980; 79(6): 1272–5PubMed
12.
go back to reference Diamant NE, Kamm MA, Wald A, et al. AGA technical review on anorectal testing techniques. Gastroenterology 1999; 116: 732–60CrossRef Diamant NE, Kamm MA, Wald A, et al. AGA technical review on anorectal testing techniques. Gastroenterology 1999; 116: 732–60CrossRef
13.
go back to reference Whitehead WE, Schuster MM. Anorectal physiology and pathophysiology. Am J Gastroenterology 1987; 82: 487–97 Whitehead WE, Schuster MM. Anorectal physiology and pathophysiology. Am J Gastroenterology 1987; 82: 487–97
15.
go back to reference Cheung O, Wald A. Review article: the management of pelvic floor disorders. Aliment Pharmacol Ther 2004; 19: 481–5PubMedCrossRef Cheung O, Wald A. Review article: the management of pelvic floor disorders. Aliment Pharmacol Ther 2004; 19: 481–5PubMedCrossRef
16.
go back to reference Read M, Read NW, Barber DC, et al. Effects of loperamide on anal sphincter function in fecal incontinence and urgency. Dig Dis Sci 1982; 27: 807–14PubMedCrossRef Read M, Read NW, Barber DC, et al. Effects of loperamide on anal sphincter function in fecal incontinence and urgency. Dig Dis Sci 1982; 27: 807–14PubMedCrossRef
17.
go back to reference Hallgren T, Fasth S, Delbro DS, et al. Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 1994; 39: 2612–8PubMedCrossRef Hallgren T, Fasth S, Delbro DS, et al. Loperamide improves anal sphincter function and continence after restorative proctocolectomy. Dig Dis Sci 1994; 39: 2612–8PubMedCrossRef
18.
go back to reference Heymen S, Jones KR, Ringel Y, et al. Biofeedback treatment for fecal incontinence: a critical review. Dis Colon Rectum 2001; 44: 728–36PubMedCrossRef Heymen S, Jones KR, Ringel Y, et al. Biofeedback treatment for fecal incontinence: a critical review. Dis Colon Rectum 2001; 44: 728–36PubMedCrossRef
20.
go back to reference Norton C, Chelvanayregam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003; 125: 1320–9PubMedCrossRef Norton C, Chelvanayregam S, Wilson-Barnett J, et al. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology 2003; 125: 1320–9PubMedCrossRef
21.
go back to reference Pettit P, Thompson JR, Chen AH. Sacral neuromodulation: new applications in the treatment of female pelvic floor dysfunction. Curr Opin Obstet Gynecol 2002; 14: 521–5PubMedCrossRef Pettit P, Thompson JR, Chen AH. Sacral neuromodulation: new applications in the treatment of female pelvic floor dysfunction. Curr Opin Obstet Gynecol 2002; 14: 521–5PubMedCrossRef
22.
go back to reference Ganio E, Masin A, Ratto C, et al. Short-term sacral nerve stimulation for functional anorectal and urinary disturbances: results in 40 patients: evaluation of a new option for anorectal functional disorders. Dis Colon Rectum 2001; 44: 1261–7PubMedCrossRef Ganio E, Masin A, Ratto C, et al. Short-term sacral nerve stimulation for functional anorectal and urinary disturbances: results in 40 patients: evaluation of a new option for anorectal functional disorders. Dis Colon Rectum 2001; 44: 1261–7PubMedCrossRef
23.
go back to reference Madoff RD. Surgical treatment options for fecal incontinence. Gastroenterology 2004; 126: 2004; 126: S48-54CrossRef Madoff RD. Surgical treatment options for fecal incontinence. Gastroenterology 2004; 126: 2004; 126: S48-54CrossRef
24.
go back to reference Karoui S, Leroi AM, Koning E, et al. Results of sphincteroplasty in 86 patients with anal incontinence. Dis Colon Rectum 2000; 43(6): 813–20PubMedCrossRef Karoui S, Leroi AM, Koning E, et al. Results of sphincteroplasty in 86 patients with anal incontinence. Dis Colon Rectum 2000; 43(6): 813–20PubMedCrossRef
25.
go back to reference Halverson AL, Hull TL. Long-term outcome of overlapping anal sphincter repair. Dis Colon Rectum 2002; 45(3): 345–8PubMedCrossRef Halverson AL, Hull TL. Long-term outcome of overlapping anal sphincter repair. Dis Colon Rectum 2002; 45(3): 345–8PubMedCrossRef
26.
go back to reference Malouf AJ, Chambers MG, Kamm MA. Clinical and economic evaluation of surgical treatments for faecal incontinence. Br J Surg 2001; 88(8): 1029–36PubMedCrossRef Malouf AJ, Chambers MG, Kamm MA. Clinical and economic evaluation of surgical treatments for faecal incontinence. Br J Surg 2001; 88(8): 1029–36PubMedCrossRef
27.
go back to reference O’Keefe EA, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair functional status and quality of life in the elderly: a population based study. J Gerontol A Biol Sci Med Sci 1995; 50: M184–9PubMedCrossRef O’Keefe EA, Talley NJ, Zinsmeister AR, et al. Bowel disorders impair functional status and quality of life in the elderly: a population based study. J Gerontol A Biol Sci Med Sci 1995; 50: M184–9PubMedCrossRef
Metadata
Title
Faecal Incontinence in the Elderly
Epidemiology and Management
Author
Professor Arnold Wald
Publication date
01-02-2005
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 2/2005
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522020-00004

Other articles of this Issue 2/2005

Drugs & Aging 2/2005 Go to the issue

Review Article

Poststroke Aphasia

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine